23 February 2017

Notice of Results

RNS Number : 6404X Verona Pharma PLC 23 February 2017

Read more

23 February 2017

Notice of Results

RNS Number : 6404X

Read more

22 February 2017

First COPD patient dosed with RPL554

RNS Number : 4893X Verona Pharma PLC 22 February 2017

Read more

13 February 2017

Total Voting Rights & Block Listing Interim Review

RNS Number : 6715W Verona Pharma PLC 13 February 2017

Read more

8 February 2017

Result of General Meeting and Share Consolidation

RNS Number : 3641W Verona Pharma PLC 08 February 2017

Read more

8 February 2017

Result of General Meeting Consolidation of Share Capital

Read more

18 January 2017

Publication of Circular

RNS Number : 4091U Verona Pharma PLC 18 January 2017

Read more

18 January 2017

Shareholder Circular for proposed consolidation, authority to issue new shares, adoption of new Articles and Notice of Meeting on 8 February 2017

Read more

18 January 2017

Proposed new Articles for adoption at Meeting on 8 February 2017

Read more

11 January 2017

Holding(s) in Company

RNS Number : 8462T Verona Pharma PLC 11 January 2017

Read more

Innovative Therapies for Respiratory Care

See the 2017 Verona Pharma corporate video 2017

Runtime: 04:05

Go

Basic & Clinical Pharmacology & Toxicology

Peer-reviewed publication on dual PDE3/4 inhibitors as novel treatments for COPD

The Lancet Respiratory Medicine

Peer-reviewed paper in the Lancet's highly-respected medication journal

Close

Verona Pharma plc
3 More London Riverside, London SE1 2RE
T: +44 (0)203 283 4200

Linkedin     Email Us